Your browser is no longer supported. Please, upgrade your browser.
FTSV Forty Seven, Inc. daily Stock Chart
FTSV [NASD]
Forty Seven, Inc.
Index- P/E- EPS (ttm)-2.47 Insider Own2.20% Shs Outstand48.14M Perf Week0.15%
Market Cap4.60B Forward P/E- EPS next Y-3.03 Insider Trans-35.92% Shs Float40.65M Perf Month1.23%
Income-87.60M PEG- EPS next Q-0.65 Inst Own69.50% Short Float2.31% Perf Quarter150.62%
Sales15.70M P/S292.86 EPS this Y35.90% Inst Trans-10.62% Short Ratio0.57 Perf Half Y1481.29%
Book/sh7.33 P/B13.03 EPS next Y-13.10% ROA-45.30% Target Price79.82 Perf Year447.96%
Cash/sh6.84 P/C13.97 EPS next 5Y- ROE-51.50% 52W Range5.53 - 95.51 Perf YTD142.60%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-0.01% Beta-
Dividend %- Quick Ratio14.80 Sales past 5Y- Gross Margin- 52W Low1627.12% ATR2.51
Employees68 Current Ratio14.80 Sales Q/Q- Oper. Margin- RSI (14)82.80 Volatility0.09% 1.60%
OptionableYes Debt/Eq0.00 EPS Q/Q34.00% Profit Margin- Rel Volume0.42 Prev Close95.51
ShortableYes LT Debt/Eq0.00 EarningsApr 02 BMO Payout- Avg Volume1.66M Price95.51
Recom2.70 SMA201.81% SMA5036.13% SMA200232.24% Volume0 Change0.00%
Jan-13-20Initiated SunTrust Buy $55
Nov-20-19Resumed Guggenheim Buy
Sep-12-19Initiated Mizuho Buy
May-29-19Initiated ROTH Capital Buy $28
Apr-12-19Initiated Guggenheim Buy
Dec-21-18Initiated BTIG Research Buy
Nov-30-18Initiated H.C. Wainwright Buy $21
Apr-03-20 10:24AM  Demand for Essential Goods Rises Amid Coronavirus: 3 Winners Zacks
Mar-30-20 10:36AM  Top Ranked Momentum Stocks to Buy for March 30th Zacks
Mar-26-20 03:03PM  SHAREHOLDER ALERT: WeissLaw LLP Reminds MEET, CBB, DLPH, and FTSV Shareholders About Its Ongoing Investigations GlobeNewswire
Mar-24-20 05:30PM  SHAREHOLDER ALERT: Monteverde & Associates PC is Investigating the Following Merger ACCESSWIRE
02:15PM  SHAREHOLDER INVESTIGATION: Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - GCAP, FTSV, MINI ACCESSWIRE
11:28AM  FTSV, MEET, MINI, and NTGN SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers GlobeNewswire
08:00AM  Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies FTSV, MINI, MEET, WLTW GlobeNewswire
Mar-23-20 04:06PM  Lifshitz Law Firm, P.C. Announces Investigation of Forty Seven, Inc., Hexcel Corporation, Legg Mason, Inc., and Mobile Mini, Inc. GlobeNewswire
Mar-20-20 04:01PM  Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights GlobeNewswire
12:15PM  SHAREHOLDER ALERT: WeissLaw LLP Reminds DLPH, FTSV, SMRT, and FHN Shareholders About Its Ongoing Investigations GlobeNewswire
Mar-19-20 02:00PM  SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Sale of These Companies; Are Shareholders Getting a Fair Deal? - ETFC, FTSV, MEET ACCESSWIRE
Mar-18-20 02:29PM  Top Biotech Stocks for Q2 2020 Investopedia
Mar-17-20 06:40PM  SHAREHOLDER ALERT: Monteverde & Associates PC is Investigating the Following Transaction ACCESSWIRE
06:00PM  SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Sale of These Companies; Are Shareholders Getting a Fair Deal? - FTSV, MINI, FSB ACCESSWIRE
04:07PM  FORTY SEVEN ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FTSV and Encourages Investors to Contact the Firm PR Newswire
02:47PM  WLTW, MEET, FTSV, and MINI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers GlobeNewswire
11:12AM  Top Small Cap Stocks for April 2020 Investopedia
10:11AM  Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies ETFC, GCAP, FTSV, MINI GlobeNewswire
Mar-12-20 05:00PM  STOCKHOLDER ALERT: Monteverde & Associates PC is Investigating the Following Merger ACCESSWIRE
12:30PM  Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - MINI, FTSV, GCAP ACCESSWIRE
10:42AM  SHAREHOLDER ALERT: WeissLaw LLP Reminds HXL, FSTV, MINI, and MEET Shareholders About Its Ongoing Investigations GlobeNewswire
Mar-11-20 03:39PM  Lifshitz & Miller LLP Announces Investigation of Forty Seven, Inc., Mobile Mini, Inc., Qiagen N.V. and The Meet Group, Inc. GlobeNewswire
12:20PM  MERGER ALERT - FTSV, GCAP, and WSC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies ACCESSWIRE
08:00AM  Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia GlobeNewswire
Mar-09-20 03:30PM  Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - FTSV, GCAP, ETFC ACCESSWIRE
02:03PM  FTSV, LM, GCAP, and TCO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts GlobeNewswire
01:32PM  Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of the Following Companies GCAP, FTSV, MINI, MEET GlobeNewswire
Mar-06-20 03:00PM  MERGER ALERT - ETFC and FTSV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies ACCESSWIRE
10:02AM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Forty Seven, Inc. - FTSV PR Newswire
Mar-05-20 06:40PM  SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: GCAP, MINI, FTSV ACCESSWIRE
03:45PM  SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - MEET, FTSV, FSCT ACCESSWIRE
Mar-04-20 09:05PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Forty Seven, Inc. (Nasdaq - FTSV) ACCESSWIRE
03:45PM  SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - GCAP, FTSV, MINI ACCESSWIRE
03:37PM  FTSV, GCAP, MINI, and FSCT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts GlobeNewswire
10:13AM  Moore Kuehn Encourages FTSV, MINI, POPE, WAAS, and TLRA Investors to Contact Law Firm PR Newswire
09:55AM  Biotech Stock Roundup: GILD to Buy Forty Seven, Pipeline Updates From BIIB & More Zacks
Mar-03-20 05:36PM  SHAREHOLDER ALERT: WeissLaw LLP Investigates Forty Seven, Inc. PR Newswire
02:31PM  FTSV Stock Attracts Options Bulls, Analysts Schaeffer's Investment Research
12:55PM  MERGER ALERT - FTSV and IOTS: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies ACCESSWIRE
09:53AM  Company News for Mar 3, 2020 Zacks
09:41AM  Gilead to Buy Immuno-Oncology Company Forty Seven for $4.9B Zacks
Mar-02-20 08:08PM  Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Mobile Mini, Forty Seven, Cincinnati Bell, and Telaria on behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire +61.91%
07:20PM  SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - MINI, FTSV, AMTD ACCESSWIRE
05:04PM  Dow bounces nearly 1,300 points as stocks end sharply higher following worst week since 2008 MarketWatch
03:00PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Forty Seven, Inc. to Gilead Sciences, Inc. is Fair to Shareholders ACCESSWIRE
12:00PM  FORTY SEVEN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout ACCESSWIRE
11:42AM  Forty Seven Merger Investigation: Halper Sadeh LLP Announces Investigation into Whether the Sale of Forty Seven, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm FTSV GlobeNewswire
10:07AM  Gilead to Buy Forty Seven for $4.9 Billion for Cancer Drug Bloomberg
09:13AM  Gilead Confirms Deal To Buy Biotech Forty Seven For $4.9B Benzinga
09:09AM  Gilead Stock Is Rising Because a Deal Will Expand Its Cancer-Drug Pipeline Barrons.com
09:00AM  (FTSV) Alert: Johnson Fistel Investigates Proposed Sale of Forty Seven, Inc.; Are Shareholders Getting a Fair Deal? PR Newswire
07:11AM  Forty Seven's stock rockets Gilead's $4.9 billion buyout deal MarketWatch
07:07AM  Gilead buys Forty Seven for $4.9 billion to bolster cancer drug pipeline Reuters
06:55AM  Gilead to Acquire Forty Seven for $4.9 Billion Business Wire
Feb-28-20 03:03PM  Gilead Sciences Could Have a Coronavirus Cure. Could It Also See a Shakeup? Barrons.com +18.88%
09:23AM  Major bank economist says the coronavirus market reaction boggles the mind MarketWatch
09:16AM  Gilead Eyes Takeover Of Cancer Biotech Forty Seven: Report Benzinga
Feb-27-20 08:29PM  Biotech company Forty Seven surges 30% after hours on report of Gilead interest MarketWatch
Feb-25-20 08:00AM  Forty Seven to Present at Upcoming Investor Conferences in March GlobeNewswire
Feb-17-20 10:06AM  3 Stocks That Are Way More Expensive Than Tesla GuruFocus.com
Feb-06-20 08:00AM  Forty Seven to Present at Upcoming Investor Conferences in February GlobeNewswire
Feb-04-20 05:09AM  Introducing Forty Seven (NASDAQ:FTSV), The Stock That Zoomed 178% In The Last Year Simply Wall St.
Jan-10-20 06:04PM  Analysts: The 5 Top Stocks Youll Want to Own In 2020 TipRanks
08:00AM  Forty Seven Announces 2020 Strategic Priorities and Expected Milestones GlobeNewswire
Dec-26-19 07:55AM  The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares Benzinga
Dec-18-19 07:05AM  2 Strong Buy Stocks That Credit Suisse Expects to Soar TipRanks
Dec-17-19 05:45PM  Do Hedge Funds Love Forty Seven, Inc. (FTSV)? Insider Monkey
Dec-16-19 04:01PM  Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares GlobeNewswire
Dec-12-19 07:38AM  The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win Benzinga +7.73%
Dec-11-19 10:32PM  Forty Seven, Inc. Prices Underwritten Public Offering of 4,860,000 Shares of Common Stock GlobeNewswire
04:01PM  Forty Seven, Inc. Announces Proposed Underwritten Public Offering of Common Stock GlobeNewswire
Dec-09-19 10:00AM  Forty Seven, Inc. Announces Foundational Preclinical Data Supporting the Development of FSI-174 in Combination with Magrolimab as a Novel All Antibody Conditioning Regimen for Hematopoietic Stem Cell Transplantation GlobeNewswire +110.73%
07:00AM  Forty Seven, Inc. Announces Updated Data from Ongoing Clinical Trial of Magrolimab Showing Robust, Durable Activity in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia GlobeNewswire
Nov-14-19 01:31PM  Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks Zacks
Nov-12-19 07:01AM  Forty Seven, Inc. Reports Third Quarter 2019 Financial Results and Recent Business Highlights GlobeNewswire +12.87%
Nov-07-19 03:07PM  Here is What Hedge Funds Think About Forty Seven, Inc. (FTSV) Insider Monkey
Nov-06-19 09:01AM  Forty Seven, Inc. to Present New Clinical and Preclinical Data on Magrolimab and FSI-174 at 61st ASH Annual Meeting GlobeNewswire +17.62%
06:31AM  Here's Why We're Watching Forty Seven's (NASDAQ:FTSV) Cash Burn Situation Simply Wall St.
Nov-05-19 08:01AM  Forty Seven Inc. to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019 GlobeNewswire
Oct-18-19 10:23AM  These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year American City Business Journals
Sep-27-19 08:01AM  Forty Seven Inc. to Present at 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-03-19 04:01PM  Forty Seven Inc. to Present at Morgan Stanley 17th Annual Global Healthcare Conference GlobeNewswire -8.18%
08:01AM  Forty Seven, Inc. Granted Fast Track Designation for Magrolimab (5F9) for the Treatment of Myelodysplastic Syndrome and Acute Myeloid Leukemia GlobeNewswire
Aug-14-19 04:07PM  Forty Seven, Inc. (FTSV) Q2 Earnings Call Transcript Motley Fool -18.98%
03:40PM  Its not just Bloom Energy: Half of last years Bay Area IPO stocks are underwater American City Business Journals
Aug-13-19 04:01PM  Forty Seven Inc. Reports Second Quarter 2019 Financial Results and Recent Business Highlights GlobeNewswire
Aug-06-19 08:01AM  Forty Seven, Inc. Announces $6 Million in Funding from the Leukemia & Lymphoma Society TAP to Accelerate the Development of 5F9 in Myelodysplastic Syndrome GlobeNewswire
Jul-31-19 08:01AM  Forty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference GlobeNewswire
Jul-29-19 08:08AM  3 Biotech Stocks Corporate Insiders are Buying TipRanks
Jul-26-19 01:11PM  Insiders Roundup: Garmin, Best Buy GuruFocus.com
Jul-22-19 04:01PM  Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares GlobeNewswire
Jul-17-19 07:15PM  Forty Seven, Inc. Prices Underwritten Public Offering of 9,375,000 Shares of Common Stock GlobeNewswire -13.44%
Jul-16-19 04:01PM  Forty Seven, Inc. Announces Proposed Underwritten Public Offering of Common Stock GlobeNewswire
Jul-11-19 10:42AM  Forty Seven Wins Exclusive License Deal For 5F9 Benzinga
08:35AM  Have Insiders Been Buying Forty Seven, Inc. (NASDAQ:FTSV) Shares? Simply Wall St.
07:00AM  Forty Seven, Inc. and Ono Pharmaceutical Co., Ltd. Sign Regional License Agreement to Develop, Manufacture and Commercialize 5F9 in Japan, South Korea, Taiwan and Select Countries in Southeast Asia GlobeNewswire
Jun-15-19 09:00AM  Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkins Lymphoma GlobeNewswire
Jun-03-19 08:00AM  Forty Seven, Inc. Announces Updated Initial Data from Phase 1b Clinical Trial of 5F9 in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia GlobeNewswire
May-16-19 09:01AM  Forty Seven, Inc. to Present Updated Data from Ongoing Phase 1b/2 Clinical Trial of 5F9 in Patients with Relapsed/Refractory Non-Hodgkins Lymphoma at 24th Congress of the European Hematology Association GlobeNewswire -19.14%
May-15-19 05:01PM  Forty Seven, Inc. to Present Initial Safety and Efficacy Data from Phase 1b Clinical Trial of 5F9 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome at 2019 ASCO Annual Meeting GlobeNewswire
Forty Seven, Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; FSI-189, an antibody that binds to SIRPa; and FSI-174, an anti-cKIT antibody. Forty Seven, Inc. has a collaboration agreement with Genentech to include third clinical trial in non-Hodgkin's lymphoma; and collaboration with Acerta Pharma to evaluate novel immuno-oncology triple combination in diffuse large B-Cell Lymphoma. The company was formerly known as CD47 Sciences, Inc. Forty Seven, Inc. was incorporated in 2014 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McCamish Mark AnthonyPresident and CEOApr 01Option Exercise4.8830,237147,63237,172Apr 03 05:50 PM
RHOADS ANN DChief Financial OfficerApr 01Option Exercise8.7620,950183,47039,338Apr 03 05:51 PM
Takimoto Chris HChief Medical OfficerApr 01Option Exercise4.7779,195377,66683,101Apr 03 05:53 PM
RHOADS ANN DChief Financial OfficerApr 01Sale95.431,924183,59837,414Apr 03 05:51 PM
McCamish Mark AnthonyPresident and CEOApr 01Sale95.4232,5773,108,5044,595Apr 03 05:50 PM
Takimoto Chris HChief Medical OfficerApr 01Sale95.4279,1957,556,7873,906Apr 03 05:53 PM
WEISSMAN IRVINGDirectorMar 12Sale93.0653,0954,941,2611,752,761Mar 16 06:01 AM
WEISSMAN IRVINGDirectorMar 11Sale94.72196,90518,650,2121,805,856Mar 16 06:01 AM
Majeti RavindraDirectorFeb 18Sale44.3825,0001,109,5141,061,400Feb 19 06:18 PM
Majeti RavindraDirectorJan 15Sale36.3525,000908,6981,086,400Jan 16 09:21 PM
WEISSMAN IRVINGDirectorDec 26Sale44.2230,0001,326,6812,002,761Dec 30 05:56 PM
Majeti RavindraDirectorDec 16Sale35.4925,000887,1681,111,400Dec 17 07:29 PM
Takimoto Chris HChief Medical OfficerDec 10Option Exercise2.0210,00020,15010,000Dec 11 09:57 PM
Takimoto Chris HChief Medical OfficerDec 10Sale35.0010,000350,0000Dec 11 09:57 PM
Takimoto Chris HChief Medical OfficerDec 09Option Exercise2.0210,00020,15010,000Dec 10 09:53 PM
Takimoto Chris HChief Medical OfficerDec 09Sale30.0010,000300,0000Dec 10 09:53 PM
WEISSMAN IRVINGDirectorDec 09Sale16.2220,000324,4092,032,761Dec 10 09:52 PM
Majeti RavindraDirectorDec 09Sale19.6265,0001,275,0001,136,400Dec 10 09:51 PM
Majeti RavindraDirectorNov 20Sale12.505,00062,5001,201,400Nov 22 06:57 PM
Majeti RavindraDirectorNov 18Sale10.2615,000153,9151,206,400Nov 20 08:01 PM